KATYA 30/75 Tablets

Katya is an oral contraceptive that contains synthetic versions of two female hormones: ethinylestradiol (an estrogen) and gestodene (a progestogen). It's equivalent to other combined pills like Femodene and Millinette 30/75. Beyond pregnancy prevention, it can help regulate periods, reduce PMS symptoms, and potentially improve skin condition.

Katya functions through multiple mechanisms to prevent pregnancy:

• Inhibits ovulation by suppressing the release of eggs from the ovaries
• Thickens cervical mucus, creating a barrier that impedes sperm movement
• Alters the uterine lining, making it less receptive to implantation

While highly effective against pregnancy, Katya does not protect against sexually transmitted infections.

• Take one tablet daily for 21 consecutive days
• Follow with a 7-day pill-free break during which a withdrawal bleed typically occurs
• Begin the next pack after the 7-day break
• For new users, start on the first day of your period for immediate protection
• If starting on any other day, use additional contraception for the first 7 days
• When switching from another contraceptive, follow specific guidelines to maintain protection

If you miss a pill:

• Less than 12 hours late: Take immediately and continue as normal (protection maintained)
• More than 12 hours late: Take immediately, continue as normal, but use additional contraception for 7 days (protection compromised)

Common side effects may include:

• Nausea and vomiting
• Abdominal discomfort
• Headaches or migraines
• Breast tenderness or enlargement
• Weight fluctuations
• Fluid retention
• Vaginal thrush
• Breakthrough bleeding

Most side effects typically improve within three months of starting treatment.

Warnings and Precautions

Katya is contraindicated for women who:

• Have a history of blood clots or are at high risk of developing them
• Have heart or liver problems
• Have had breast cancer or genital organ cancers
• Experience migraines with aura
• Have high blood pressure
• Have elevated blood fat levels

The risk of blood clots is particularly increased:

• During the first year of use
• With advancing age
• With obesity
• With a family history of clots
• After surgery or during prolonged immobilization

There is a slightly increased risk of breast cancer with combined hormonal contraceptives.

Katya should not be used during pregnancy or while breastfeeding. Regular breast self-examinations are recommended for all users.